HC Wainwright Maintains Buy Rating on Harmony Biosciences, Keeps $55 Target
HC Wainwright maintained its Buy rating and $55 price target on Harmony Biosciences. The target implies 60.7% upside from the Nov. 11 close of $34.22.
HC Wainwright maintained its Buy rating and $55 price target on Harmony Biosciences. The target implies 60.7% upside from the Nov. 11 close of $34.22.